Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Maybe we are all looking at it from the wrong perspective...

Maybe we are all looking at it from the wrong perspective...

posted on Feb 15, 2008 05:45AM

let's look at it from PTSC perspective: (in a outline format)

-NDA items, play it safe, not discuss anything that might cause trouble.

-Licenses right now don't seem to do much for shareprice (ptsc mgmt. know about s&l dumping). So why not wait for April.

-M&A discussion is mute until an actually merger occurrs so what the benefit (shareprice into this market) just discussing possiblities.

-Shareholders are pissed, but what can we do (see above) have to wait it out.

 

Now I am sure others will chime in for PTSC mgmt. Maybe they are actually stuck and would like to do the right thing. A big plus would be if some insiders buy on the open market after April news.

glta

Tom

Share
New Message
Please login to post a reply